SOAN
Price:
$0.06834
Market Cap:
$0
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
Industry
Biotechnology
IPO Date
2022-01-31
Stock Exchange
OTC
Ticker
SOAN
According to AngioSoma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -21792.00. This represents a change of -100.08% compared to the average of 27.83M of the last 4 quarters.
The mean historical Enterprise Value of AngioSoma, Inc. over the last ten years is 3.42M. The current -21792.00 Enterprise Value has changed -163.70% with respect to the historical average. Over the past ten years (40 quarters), SOAN's Enterprise Value was at its highest in in the June 2021 quarter at 32.09M. The Enterprise Value was at its lowest in in the June 2013 quarter at -158207.20.
Average
3.42M
Median
1.41M
Minimum
-46092.40
Maximum
20.35M
Discovering the peaks and valleys of AngioSoma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.31%
Maximum Annual Enterprise Value = 20.35M
Minimum Annual Increase = -678.69%
Minimum Annual Enterprise Value = -46092.40
| Year | Enterprise Value | Change |
|---|---|---|
| 2020 | 20.35M | 417.13% |
| 2019 | 3.94M | -4.38% |
| 2018 | 4.12M | 47.10% |
| 2017 | 2.80M | 17.27% |
| 2016 | 2.39M | 455.69% |
| 2015 | 429.32K | 60.95% |
| 2014 | 266.73K | -678.69% |
| 2013 | -46092.40 | 6.31% |
| 2012 | -719.61 | -96.67% |
| 2011 | -21634.47 | 151.14% |
The current Enterprise Value of AngioSoma, Inc. (SOAN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.47M
5-year avg
6.72M
10-year avg
3.42M
AngioSoma, Inc.’s Enterprise Value is less than LakeShore Biopharma Co., Ltd (624.71M), less than IntelGenx Technologies Corp. (42.91M), less than Alpha Cognition Inc. (34.21M), less than ImmuPharma plc (30.05M), less than Small Pharma Inc. (33.72M), less than IBEX Technologies Inc. (28.63M), less than Pharmaxis Ltd (13.05M), less than OKYO Pharma Limited (76.67M), less than Kadimastem Ltd (133.31M), less than Enzo Biochem, Inc. (2.90M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 624.71M | $33.79M | |
| 42.91M | $29.69M | |
| 34.21M | $35.66M | |
| 30.05M | $28.34M | |
| 33.72M | $37.51M | |
| 28.63M | $25.27M | |
| 13.05M | $31.04M | |
| 76.67M | $22.73M | |
| 133.31M | $9.50M | |
| 2.90M | $36.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AngioSoma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AngioSoma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AngioSoma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for AngioSoma, Inc. (SOAN)?
What is the 3-year average Enterprise Value for AngioSoma, Inc. (SOAN)?
What is the 5-year average Enterprise Value for AngioSoma, Inc. (SOAN)?
How does the current Enterprise Value for AngioSoma, Inc. (SOAN) compare to its historical average?